Yoichi Sakata

Title: Yoichi Sakata: Innovator in Human Protein Research

Introduction

Yoichi Sakata is a prominent inventor based in Oyama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical diagnostics and therapeutic applications.

Latest Patents

Sakata holds 2 patents, with his latest innovations focusing on human tissue plasminogen activator and human protein C. One of his notable patents is a monoclonal antibody that specifically targets human protein C when calcium is bound at the gamma-carboxyglutamic acid (Gla) domain. This antibody does not recognize human protein C that is not bound to calcium at the Gla domain. The monoclonal antibody is utilized in an immunoassay method for determining human protein C with a Gla domain and in a method for recovering human protein C.

Career Highlights

Yoichi Sakata is associated with Teijin Limited, a company known for its advancements in various fields, including healthcare and materials. His work at Teijin has allowed him to focus on innovative solutions that address critical health issues.

Collaborations

Sakata collaborates with esteemed colleagues, including Kenji Wakabayashi and Yoshihiko Sumi. Their combined expertise enhances the research and development efforts within their projects.

Conclusion

Yoichi Sakata's contributions to biotechnology, particularly in the area of monoclonal antibodies, highlight his role as an innovator in the field. His patents and collaborations continue to pave the way for advancements in medical diagnostics and treatment.